Understanding Peru’s New Regulation on the medicinal and therapeutic use of cannabis and its derivatives

Peru is updating its legislation to regulate the medicinal and therapeutic use of cannabis and its derivatives.

The New Regulation – Supreme Decree No. 004-2023-SA – comes into force on September 1, 2023.

The New Regulation:

• Strengthens the regulation, scope and coverage of the use of cannabis and its derivatives for medical and therapeutic purposes.


• Regulates, in a more specific manner, the parameters and/or requirements so that those who are administered may carry out research, production, importation, and commercialization of cannabis and its derivatives and artisanal production of cannabis derivatives with associative cultivation.


• Establishes detailed control and supervision mechanisms to ensure that cannabis and its derivatives are used exclusively for medicinal and therapeutic purposes, thus granting other public entities control and supervision faculties.

In this concise report, we summarize the top points of the New Regulation and the changes it will bring to Peruvian law.

Download the report in English.

Descarga el informe en español.

This report was prepared by the Life Sciences team of DLA Piper Peru. To find out more about the developments covered in this report and our life sciences work in Peru, please contact any of the authors:

Ana Teresa Barreto
Of Counsel

Jorge Córdova
Partner

Nicole Allemant
Associate

Nathalie Málaga
Associate

Hiroshi Sugashima
Associate